Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Cancer Survival Analysis01:21

Cancer Survival Analysis

402
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
402
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

228
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
228
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

160
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
160
Introduction To Survival Analysis01:18

Introduction To Survival Analysis

301
Survival analysis is a statistical method used to study time-to-event data, where the "event" might represent outcomes like death, disease relapse, system failure, or recovery. A unique feature of survival data is censoring, which occurs when the event of interest has not been observed for some individuals during the study period. This requires specialized techniques to handle incomplete data effectively.
The primary goal of survival analysis is to estimate survival time—the time...
301
Actuarial Approach01:20

Actuarial Approach

101
The actuarial approach, a statistical method originally developed for life insurance risk assessment, is widely used to calculate survival rates in clinical and population studies. This method accounts for participants lost to follow-up or those who die from causes unrelated to the study, ensuring a more accurate representation of survival probabilities.
Consider the example of a high-risk surgical procedure with significant early-stage mortality. A two-year clinical study is conducted,...
101
Kaplan-Meier Approach01:24

Kaplan-Meier Approach

197
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
197

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

An Overview and Recent Developments in the Analysis of Multistate Processes.

Statistics in medicine·2026
Same author

Expected life years compared to the general population.

Biometrical journal. Biometrische Zeitschrift·2023
Same author

The Relative Preservation of the Central Retinal Layers in Leber Hereditary Optic Neuropathy.

Journal of clinical medicine·2022
Same author

Is It Possible to Predict Clonal Thrombocytosis in Triple-Negative Patients with Isolated Thrombocytosis Based Only on Clinical or Blood Findings?

Journal of clinical medicine·2021
Same author

COVID-19 in Slovenia, from a Success Story to Disaster: What Lessons Can Be Learned?

Life (Basel, Switzerland)·2021
Same author

Nutritional Status and Health-Related Quality of Life in Men with Advanced Castrate-Resistant Prostate Cancer.

Nutrition and cancer·2021
Same journal

When to Adjust for Multiple Testing: A Unifying Guiding Principle.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Ensuring Quality in Preclinical Research: The Importance of Being Human.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Addressing Cluster-Level Treatment Effect Heterogeneity in Sample Size Determination for Hierarchical 2 × 2 Factorial Designs.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

A Multiple Imputation Approach to Distinguish Curative From Life-Prolonging Effects in the Presence of Missing Covariates.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Tests for Categorical Data Beyond Pearson: A Distance Covariance and Energy Distance Approach.

Biometrical journal. Biometrische Zeitschrift·2026
Same journal

Nonparametric Estimation of the Patient-Weighted While-Alive Estimand.

Biometrical journal. Biometrische Zeitschrift·2026
查看所有相关文章

相关实验视频

Updated: Jul 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

307

评估使用生存分析的癌症查计划.

Bor Vratanar1, Maja Pohar Perme1

  • 1Institute for Biostatistics and Medical Informatics, Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia.

Biometrical journal. Biometrische Zeitschrift
|June 6, 2023
PubMed
概括
此摘要是机器生成的。

癌症查旨在通过早期检测改善生存率. 这项研究引入了一种新方法,通过考虑诸如头时间和过度检测等偏差来准确估计生存益处.

关键词:
偏见 偏见 偏见 偏见 偏见乳腺癌 乳腺癌 乳腺癌癌症查 癌症查这是一个反事实性的反事实.生存分析,生存分析.

更多相关视频

Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

相关实验视频

Last Updated: Jul 27, 2025

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery
06:46

Competing-Risk Nomogram for Predicting Cancer-Specific Survival in Multiple Primary Colorectal Cancer Patients after Surgery

Published on: September 27, 2024

307
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.2K
An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.1K

科学领域:

  • 在瘤学瘤学.
  • 生物统计学 生物统计学
  • 流行病学 流行病学

背景情况:

  • 癌症查计划旨在通过早期诊断和治疗来改善患者的生存率.
  • 直接测试查的生存益处需要将查检测到的病例与未查的同行进行比较.
  • 纯粹的比较往往会因为诸如领先时间,长度偏差和过度检测等因素而有偏见.

研究的目的:

  • 开发一种正式的标记来比较查检测的癌症病例与未查的人群的生存率.
  • 识别和分解查计划中天真生存比较中固有的偏见.
  • 提出一种新的非参数估计器,以准确评估癌症查的真实生存优势.

主要方法:

  • 制定一个一般的标记来定义癌症查研究中兴趣的比较.
  • 偏差的分析和分解,包括领先时间偏差,长度时间偏差和过度检测偏差.
  • 引入一个新的非参数估计器来量化假设查检测对照组的生存率.

主要成果:

  • 在查检测和间隔癌症病例之间的天真比较显然有偏见.
  • 现有的方法可以估计偏差的一些组成部分,但在估计对照组的生存率方面仍然存在差距.
  • 提出的非参数估计器成功填补了这一差距,使得真实生存对比率的估计成为可能.

结论:

  • 准确估计癌症查的好处需要解决头时间,长度时间和过度检测偏差.
  • 开发的非参数估计器允许全面评估查计划的有效性.
  • 这种方法提供了一种更可靠的方法来评估癌症查对患者存活时间的影响.